This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of the pharmaceutical product VERQUVO 5 MG TABLET 30S. The contract has a firm fixed price of $2,729.58 and an ultimate completion date of August 2, 2024. No set-aside designation was used for this award. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,705.63, is for the delivery of the drug VERQUVO 10 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 28, 2024. The contract was awarded on October 25, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,004.82 firm fixed-price delivery order contract provides for the supply of the pharmaceutical product VERQUVO 5 MG TABLET 30S. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,912.92, is for the supply of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there are no set-aside requirements indicated for this award. The...
This federal contract award, valued at $1,354.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $4,396.10 firm fixed-price contract is for the delivery of VERQUVO 10 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. The award has an ultimate completion date of November 19, 2024 and was issued on November 18, 2024. This contract is not...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,854.78 contract is for the supply of VERQUVO 5 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of June 10, 2024 and was issued on June 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The federal contract award summarized in the provided information is for the delivery of VERQUVO 2.5 MG TABLET 30S pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor for this $28,684.71 firm fixed price delivery order contract is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024, with no set-aside requirements....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,766.15 firm fixed-price delivery order is for the supply of the medication VERQUVO 2.5 MG TABLET 30S, with a completion date of December 9, 2024. The award is not designated as a set-aside contract. It appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $1,087.74, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...